Saxagliptin

Generic Name
Saxagliptin
Brand Names
Kombiglyze, Komboglyze, Onglyza, Qtern, Qternmet
Drug Type
Small Molecule
Chemical Formula
C18H25N3O2
CAS Number
361442-04-8
Unique Ingredient Identifier
8I7IO46IVQ
Background

Saxagliptin (rINN) is an orally active hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. FDA approved on July 31, 2009.

Indication

Treatment of type 2 diabetes mellitus to improve glycemic control in combination with other agents or as monotherapy.

Associated Conditions
Type 2 Diabetes Mellitus
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath